Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
Strategic Plan
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Entyvio (SC) (vedolizumab)
pCPA File Number:
21228
Negotiation Status:
Concluded with an LOI
Indication(s):
Ulcerative Colitis
Sponsor/Manufacturer:
Takeda Canada Inc.
CADTH Project Number:
SR0635-000
pCPA Engagement Letter Issued:
2020-10-19
Negotiation Process Concluded:
2021-08-13